Screener
Pulmonx Corporation LUNG Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $22.76M-4.6% | $20.59M-8.7% | $22.6M-4.9% | $21.5M+5.5% | $23.86M+14.8% | ||
| $5.01M-24.7% | $4.54M-26.7% | $5.06M-18.1% | $5.45M+1.7% | $6.66M+21.5% | ||
| $17.74M+3.1% | $16.04M-1.8% | $17.54M-0.3% | $16.05M+6.8% | $17.2M+12.4% | ||
| 78%+5.9pp | 77.9%+5.4pp | 77.6%+3.6pp | 74.7%+0.9pp | 72.1%-1.5pp | ||
| $5.03M-5.1% | $4.9M+3.0% | $4.58M+14.5% | $4.85M+29.4% | $5.31M-5.5% | ||
| $21.77M-18.5% | $24.1M-7.8% | $22.86M-15.3% | $25.6M+0.7% | $26.7M+5.5% | ||
| $26.8M-16.3% | $29M-6.2% | $27.44M-11.5% | $30.45M+4.4% | $32.01M+3.5% | ||
| -$9.06M+38.8% | -$12.96M+11.0% | -$9.9M+26.2% | -$14.39M-1.9% | -$14.8M+5.2% | ||
| -39.8%+22.2pp | -62.9%+1.7pp | -43.8%+12.6pp | -66.9%+2.4pp | -62%+13.1pp | ||
| $1.22M+52.4% | $976K+25.0% | $770K-8.6% | $805K-9.7% | $799K-10.3% | ||
| -$1K+99.1% | $77K-53.9% | $0-100% | $758K+477% | -$116K-231% | ||
| -$9.95M+33.7% | -$13.51M+5.6% | -$10.24M+22.1% | -$13.83M+0.9% | -$15M+1.6% | ||
| $133K-24.9% | $149K+10.4% | $186K+389% | $128K-33.3% | $177K+111% | ||
| -$10.08M+33.6% | -$13.65M+5.5% | -$10.43M+20.9% | -$13.96M+1.3% | -$15.17M+1.0% | ||
| -44.3%+19.3pp | -66.3%-2.2pp | -46.1%+9.3pp | -64.9%+4.5pp | -63.6%+10.1pp | ||
| -$0.24+36.8% | -$0.33+8.3% | -$0.25+24.2% | -$0.34+5.6% | -$0.38+2.6% | ||
| -$8.84M+39.1% | -$12.74M+10.8% | -$9.67M+26.3% | -$14.15M-2.9% | -$14.51M+4.7% | ||
| -38.8%+22.0pp | -61.9%+1.5pp | -42.8%+12.4pp | -65.8%+1.7pp | -60.8%+12.4pp | ||
| -$9.06M+38.8% | -$12.96M+11.0% | -$9.9M+26.2% | -$14.39M-1.9% | -$14.8M+5.2% |
FAQ
- What is Pulmonx Corporation's revenue?
- Pulmonx Corporation (LUNG) generated $87.4M in revenue over the trailing twelve months, down 3.4% year over year.
- Is Pulmonx Corporation profitable?
- Pulmonx Corporation is not currently profitable: it reported a net loss of $48.1M over the trailing twelve months, a -55.0% net margin.
- What are Pulmonx Corporation's profit margins?
- Gross margin is 77.1% and operating margin is -53.0%, with a -55.0% net margin.
- What is Pulmonx Corporation's earnings per share?
- Pulmonx Corporation's diluted EPS over the trailing twelve months is $-1.16.
- Where does Pulmonx Corporation's income statement data come from?
- Every line is extracted from Pulmonx Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
